Workshop held on December 2, 2017, Leuven, Belgium
Cardiovascular phenotype in children and adults with ADPKD
Francesco Emma, Rome, Italy
Pathways involved in ADPKD
Barbara Ehrlich, New Haven, USA
I´ll have my cysts with a bit of sugar, please
Detlef Bockenhauer, London, UK
Genetics of Polycystic Kidney Diseases
Peter Harris, Rochester, USA
Vicente Torres, Rochester, USA
Clinical Management of ADPKD in the era of Tolvaptan
Roman Müller, Cologne, Germany
Practices and ethical issues in ADPKD: from survey to registry
Djalila Mekahli, Leuven, Belgium
KDIGO Consensus for the management of ADPKD in adults
Roser Torra, Barcelona, Spain
Lessons from CRISP, HALT PKD, TEMPO and the PKD Outcomes Consortium: TKV and other Biomarkers
Ron Perrone, Boston, USA
Patient Engagement in ADPKD and ARPKD: The role of patients organisations
Tess Harris, Patient Point of view, London, UK